Form 4: Moderna President Stephen Hoge Reports Stock Transactions

Moderna's President, Stephen Hoge, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• Stephen Hoge, President of Moderna, reported transactions involving Moderna's common stock.
• On August 28, 2024, 611 restricted stock units (RSUs) vested and converted into common stock.
• Also on August 28, 2024, Hoge acquired 611 shares.
• On August 29, 2024, 300 shares were sold at a price of $78.026 per share to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Hoge directly owns 1,442,668 shares of Moderna common stock.
• Hoge also indirectly owns 4,116 shares through Valhalla, LLC and 151,933 shares through a trust for the benefit of his spouse and children.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholder sentiment, but the amount is relatively small.

Key Dates